| Health / Medical Topics |
Efungumab
A human single-chain variable fragment of a monoclonal antibody against fungal Hsp90 with anti-fungal activity. Efungumab binds to heat shock protein 90 (Hsp90) located on the fungal cell surface, thereby preventing cell wall synthesis and repair. This decreases the integrity of the fungal cell wall and prevents further fungal cell growth. In addition, as Hsp90 is a molecular chaperone, inhibition of its function may increase the cytotoxic effect of other antifungal agents. (NCI Thesaurus)
YOU MAY ALSO LIKE
A drug used to treat cancers of the breast, stomach, and pancreas, and certain types of colorectal and head and neck…
A group of cancers that includes Ewing tumor of bone (ETB or Ewing sarcoma of bone), extraosseous Ewing (EOE) tumors, primitive neuroectodermal…
A preparation of autologous, CD34-positive stem/progenitor cells transduced with a lentrivral vector encoding the human adenosine deaminase (ADA) gene under the control…
In cancer, the length of time after primary treatment for a cancer ends that the patient remains free of certain complications or…
The estrogen-inducible RING finger protein Efp stimulates proliferation of breast cancer cells. 14-3-3 is p53-inducible protein that sequesters mitotic Cdks in the…
Human EFNB2 wild-type allele is located in the vicinity of 13q33 and is approximately 45 kb in length. This allele, which encodes…
